Last reviewed · How we verify
NCT04436263: NAPE
Cardioprotective Properties of Natural Anti-Platelet Activating Factor Extract From Winery By-products in Healthy Women
NA trial testing Supplement in Platelet Aggregation and Inflammation in 15 participants. Status unknown.
20 June 2021
Quick facts
| Lead sponsor | Harokopio University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 15 |
| Start date | 20 January 2020 |
| Primary completion | 20 June 2021 |
| Estimated completion | 20 June 2021 |
| Sites | 1 location across Greece |
Drugs / interventions tested
- Supplement
- Placebo
Conditions studied
- Platelet Aggregation and Inflammation — all drugs for Platelet Aggregation and Inflammation →
Sponsor
Harokopio University
Who can join
Adults 25 to 45, female only, with Platelet Aggregation and Inflammation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to investigate the anti-platelet and anti-inflammatory properties of a winery by-products extract as well as to detect extract compounds and their metabolites in biological fluids. The study is a randomized, double-blind, crossover, placebo controlled postprandial study in healthy women.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Postprandial Metabolic and Oxidative Stress Responses to Grape Pomace Extract in Healthy Normal and Overweight/Obese Women: A Randomized, Double-Blind, Placebo-Controlled Crossover Study.
Choleva M, Matalliotaki E, Antoniou S, Asimomyti E, et al · · 2022 · cited 9× · PMID 36615813 · DOI 10.3390/nu15010156
Verify or expand the search:
- PubMed search for NCT04436263
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Supplement
Trials testing the same drug.
- NCT05976035 — Exercise vs. Supplements in Rotator Cuff-Related Shoulder Pain · NA · not yet recruiting
- NCT07213063 — Effects of Chronic Creatine and Beta-Hydroxy-Beta-Methylbutyrate Supplementation on Oxidative Stress, Inflammation, Musc · NA · recruiting
- NCT07117110 — Lycopene as a Dietary Compliance Biomarker · NA · recruiting
- NCT07024940 — Short-term Effects of Caffeine and a Multi-ingredient Pre-workout on Exercise Performance · NA · recruiting
- NCT06722898 — Rapid BAC Reduction with Nutraceutical Blend Study · Phase 2 · not yet recruiting
Other Harokopio University trials
Trials by the same sponsor.
- NCT06997510 — Better4All Personalized Intervention · NA · not yet recruiting
- NCT07233707 — Load and Hold: Impact of 7-Day Creatine Monohydrate Loading on Breath-Hold Cycling Performance · NA · enrolling by invitation
- NCT07505680 — Time-restricted Feeding and Health · NA · completed
- NCT07120802 — Better4All Personalized Intervention Pilot Study · NA · recruiting
- NCT07190066 — MELIORA Data Collection Campaigns · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04436263 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Harokopio University
- Last refreshed: 18 June 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04436263.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing